AMICUS THERAPEUTICS, INC. Repayments of Long-Term Debt
AMICUS THERAPEUTICS, INC. reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2020-12-31 was $0.00.
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2019-12-31 was $0.00.
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for fiscal 2025 was $0.00.
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for fiscal 2023 was $408.04M.
- AMICUS THERAPEUTICS, INC. repayments of long-term debt for fiscal 2022 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-20 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-20 | ||
| 2023-12-31 | $408.04M 10-K · filed 2026-02-20 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-19 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $155.25M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $155.25M 10-Q · filed 2021-11-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |